Cargando…
Consider Nitrofurantoin as a Cause of Lung Injury
Nitrofurantoin-induced diffuse lung toxicity is well documented in the literature but is often misdiagnosed. We describe an 82-year-old female medicated with nitrofurantoin for the previous 2 years who was admitted for dyspnoea, dry cough and fatigue for 4 months. She was febrile and tachypnoeic and...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886637/ https://www.ncbi.nlm.nih.gov/pubmed/31890712 http://dx.doi.org/10.12890/2019_001295 |
_version_ | 1783474903283924992 |
---|---|
author | Almeida, Paulo Seixas, Eduarda Pinheiro, Beatriz Ferreira, Pedro Araújo, Ana |
author_facet | Almeida, Paulo Seixas, Eduarda Pinheiro, Beatriz Ferreira, Pedro Araújo, Ana |
author_sort | Almeida, Paulo |
collection | PubMed |
description | Nitrofurantoin-induced diffuse lung toxicity is well documented in the literature but is often misdiagnosed. We describe an 82-year-old female medicated with nitrofurantoin for the previous 2 years who was admitted for dyspnoea, dry cough and fatigue for 4 months. She was febrile and tachypnoeic and she presented with bilateral basal crackles, hypoxaemic respiratory failure and slightly elevated C-reactive protein levels. A chest radiograph showed bilateral air-space consolidation and interstitial infiltrates and the high-resolution computed tomography scan was evocative of a perilobular pattern of organising pneumonia (OP). Due to the clinical–radiological context, she was diagnosed with a presumable nitrofurantoin-induced OP. She was started on prednisolone 60 mg daily with a progressive improvement. It is important that clinicians are aware of the spectrum of side effects associated with nitrofurantoin so as to monitor patients. LEARNING POINTS: It is crucial to ensure that a thorough medical history with a systems review and a complete drug history are carried out. Chronic pulmonary toxicity due to nitrofurantoin is rare and it occurs primarily in older women who have been prescribed relatively small doses of nitrofurantoin for UTI prevention. The cessation of nitrofurantoin is the basis of the treatment and may be sufficient for clinical and radiological improvement. |
format | Online Article Text |
id | pubmed-6886637 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SMC Media Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-68866372019-12-30 Consider Nitrofurantoin as a Cause of Lung Injury Almeida, Paulo Seixas, Eduarda Pinheiro, Beatriz Ferreira, Pedro Araújo, Ana Eur J Case Rep Intern Med Articles Nitrofurantoin-induced diffuse lung toxicity is well documented in the literature but is often misdiagnosed. We describe an 82-year-old female medicated with nitrofurantoin for the previous 2 years who was admitted for dyspnoea, dry cough and fatigue for 4 months. She was febrile and tachypnoeic and she presented with bilateral basal crackles, hypoxaemic respiratory failure and slightly elevated C-reactive protein levels. A chest radiograph showed bilateral air-space consolidation and interstitial infiltrates and the high-resolution computed tomography scan was evocative of a perilobular pattern of organising pneumonia (OP). Due to the clinical–radiological context, she was diagnosed with a presumable nitrofurantoin-induced OP. She was started on prednisolone 60 mg daily with a progressive improvement. It is important that clinicians are aware of the spectrum of side effects associated with nitrofurantoin so as to monitor patients. LEARNING POINTS: It is crucial to ensure that a thorough medical history with a systems review and a complete drug history are carried out. Chronic pulmonary toxicity due to nitrofurantoin is rare and it occurs primarily in older women who have been prescribed relatively small doses of nitrofurantoin for UTI prevention. The cessation of nitrofurantoin is the basis of the treatment and may be sufficient for clinical and radiological improvement. SMC Media Srl 2019-10-30 /pmc/articles/PMC6886637/ /pubmed/31890712 http://dx.doi.org/10.12890/2019_001295 Text en © EFIM 2019 This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Articles Almeida, Paulo Seixas, Eduarda Pinheiro, Beatriz Ferreira, Pedro Araújo, Ana Consider Nitrofurantoin as a Cause of Lung Injury |
title | Consider Nitrofurantoin as a Cause of Lung Injury |
title_full | Consider Nitrofurantoin as a Cause of Lung Injury |
title_fullStr | Consider Nitrofurantoin as a Cause of Lung Injury |
title_full_unstemmed | Consider Nitrofurantoin as a Cause of Lung Injury |
title_short | Consider Nitrofurantoin as a Cause of Lung Injury |
title_sort | consider nitrofurantoin as a cause of lung injury |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886637/ https://www.ncbi.nlm.nih.gov/pubmed/31890712 http://dx.doi.org/10.12890/2019_001295 |
work_keys_str_mv | AT almeidapaulo considernitrofurantoinasacauseoflunginjury AT seixaseduarda considernitrofurantoinasacauseoflunginjury AT pinheirobeatriz considernitrofurantoinasacauseoflunginjury AT ferreirapedro considernitrofurantoinasacauseoflunginjury AT araujoana considernitrofurantoinasacauseoflunginjury |